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suppressed Rac activation in neutrophils and consequently inhibited their infiltration to the skin. Unlike 
17,18-EpETE, its metabolite 17,18-diHETE did not show any effects on contact hypersensitivity. It was 
also shown that therapeutic treatment of 17,18-EpETE ameliorated contact hypersensitivity in 
cynomolgus monkey. These results indicate that 17,18-EpETE could be applied to be a therapeutic 
agent for the control of allergic inflammatory diseases.  
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Along the process of epithelial self-renewal, antigens derived from apoptotic intestinal epithelial cells 
(IECs) are taken up by antigen presenting cells (APCs), transported to the gut-draining lymph nodes 
and cross-presented to CD8 T cells. In steady state, rapid tolerization of CD8 T cells reactive towards 
epithelial-derived antigens is crucial to maintain tissue homeostasis. In contrast, infection of IECs by 
intracellular pathogens requires induction of cytotoxic CD8 T cells (CTLs) towards epithelial-
associated, pathogen-derived antigens. Currently, little is known about the regulation of CD8 T cells by 
intestinal APCs in these two different contexts. Since IRF8-dependent dendritic dells (IRF8-DCs) have 
superior cross-presenting capabilities, we aimed to investigate their role in this process. IFABP-tOva 
mice, expressing the model-antigen Ovalbumin (Ova) in IECs, were used as recipients to set up 
chimeras using either CD11c-cre.Irf8fl/fl bone marrow, which cannot generate IRF8-DCs, or cre-
negative Irf8fl/fl control bone marrow. Whereas transfer of Ova-specific CD8 T cells (OT-I cells) to 
steady state control chimeras resulted in their rapid tolerization, OT-I cells transferred to CD11c-
cre.Irf8fl/fl chimeras spontaneously developed into CTLs, causing epithelial destruction and intestinal 
inflammation. However, when the TLR7-ligand R848 was applied as an inflammatory trigger mimicking 
viral infection in addition to OT-I transfer, expansion of CTLs occurred at similar rates in both, CD11c-
cre.Irf8fl/fl and control chimeras. Taken together, this demonstrates that IRF8-DCs are crucial for the 
rapid tolerization of CD8 T cells reactive towards epithelial-derived antigen in steady state, but are not 
essential for the induction of CTLs in an inflammatory setting such as found in infection.  
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Dendritic cells (DCs) respond to microbial cues by activating several coordinated metabolic and gene 
expression programs that altogether maximize their capacity to orchestrate immune responses. 
Translation of costimulatory molecules, cytokines and other induced mRNAs is an essential part of the 
program and it is tightly regulated. Recently, a connection between ribosomal speed of elongation, 
mRNA stability and protein expression has been found tumors and model organisms. Analysing 
microarray data, we found that genes involved in tRNAs metabolism were coordinately regulated 
during the first hours after DC activation, suggesting a role connecting transcriptional and translational 
programs during DCs maturation. To test this hypothesis, we performed tRNA microarrays, codon 
usage analysis in DC transcriptomic data, and studied the effect of modulating tRNA metabolic 
pathways in the capacity of DCs mature in response to different stimuli. We have found, an essential 
inducible regulatory program in DCs that involves qualitative and quantitative changes in the tRNA 
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